Commentary: Genetic modulation in lung transplantation: Epic odyssey of vector transduction and transgene expression
The Journal of Thoracic and Cardiovascular Surgery · 2023-07 · 166 (1) · e50-e51
DOI: 10.1016/j.jtcvs.2022.10.006 ↗Kurz gefasst
Editorial in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2023-07. Verfasst von Jan Van Slambrouck und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Depa…. Hauptthemen laut MEDLINE: Gene Transfer Techniques, Lung Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: Medtronic, Fonds Wetenschappelijk Onderzoek, KU Leuven.
Abstract (Originalsprache)
Genetic lung modulation is a novel strategy to overcome the challenges that hamper further improvement of lung transplantation (LTx) outcome. We congratulate the authors for embarking on this odyssey in search of an efficient delivery vector and route. Previously, in the field of LTx, adeno-and lentiviral vectors have been investigated. 1,2 However, the adeno-associated viral (AAV) vector is characterized by lower pathogenicity, lower risk for genomic integration, stable transgene expression, and existing clinical applications. 3 Kesseli and colleagues 4 from Duke University assessed for the first time in a syngeneic rat model of orthotopic left LTx the potential to genetically target the donor lung ex vivo with AAV. A low/high dose (8e 10 /4e 11 copies) of AAV9 was delivered ex vivo in the bronchus or pulmonary artery, before 60 minutes of static cold storage. Reporter gene expression was assessed with immunohistochemistry after 2 weeks (green fluorescent protein, mCherry) and in vivo or tissue luminescence (Luciferase) up to 2 months after delivery. Bronchial delivery resulted in epithelial expression. Arterial instillation did not result in clear endothelial expression but led to off-target expression in liver and heart. 4
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
- Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium; Department of Pharmaceutical and Pharmacological Sciences, Molecular Virology…
- Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.…
Förderung
- Medtronic
- Fonds Wetenschappelijk Onderzoek
- KU Leuven
- Broere Charitable Foundation
Zitieren
APA
Van Slambrouck, J., Carlon, M. S., Van Raemdonck, D., & Ceulemans, L. J. (2023). Commentary: Genetic modulation in lung transplantation: Epic odyssey of vector transduction and transgene expression. The Journal of Thoracic and Cardiovascular Surgery, 166(1), e50-e51. https://doi.org/10.1016/j.jtcvs.2022.10.006
Vancouver
Van Slambrouck J, Carlon MS, Van Raemdonck D, Ceulemans LJ. Commentary: Genetic modulation in lung transplantation: Epic odyssey of vector transduction and transgene expression. The Journal of Thoracic and Cardiovascular Surgery. 2023;166(1):e50-e51. doi:10.1016/j.jtcvs.2022.10.006
BibTeX
@article{VanSlambrouck2023,
author = {Van Slambrouck, Jan and Carlon, Marianne S and Van Raemdonck, Dirk and Ceulemans, Laurens J},
title = {Commentary: Genetic modulation in lung transplantation: Epic odyssey of vector transduction and transgene expression},
journal = {The Journal of Thoracic and Cardiovascular Surgery},
year = {2023},
volume = {166},
number = {1},
pages = {e50--e51},
doi = {10.1016/j.jtcvs.2022.10.006}
}
EUVIMED